Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Fintech PR

Cognizant Unveils Advanced Artificial Intelligence Lab to Accelerate AI Research and Innovation

Published

on

cognizant-unveils-advanced-artificial-intelligence-lab-to-accelerate-ai-research-and-innovation

With 75 issued and pending patents, the lab will launch with a team of dedicated AI researchers and developers; focus will be on research, innovation and production of cutting-edge AI systems

TEANECK, N.J., March 7, 2024 /PRNewswire/ — Cognizant (Nasdaq: CTSH), a leading global technology company, today announced the launch of an Advanced Artificial Intelligence (AI) Lab. The lab, based in San Francisco, will focus on advancing the science and practice of AI through innovation and development of intellectual property and AI-enablement technologies. Staffed by a team of researchers and developers, including AI pioneers and PhDs, the lab will collaborate with research institutions, customers, and startups and already has 75 issued and pending patents that provide a differentiated foundation on which to build cutting edge AI solutions. The lab is part of the commitment Cognizant announced last year to invest $1 billion in generative AI (gen AI) over the next three years.

The launch of Cognizant’s Advanced AI Lab comes at a time when enterprises are rapidly working to understand the impact of AI and meet expanding expectations around its promise. Recent research has shown more than half (66 percent) of executives are ambivalent or dissatisfied with their company’s progress on AI and gen AI, and most executives (85 percent) plan to increase spending on AI and gen AI in 2024. Longer term, Cognizant and Oxford Economics’ recent study found gen AI could inject up to $1 trillion to the U.S. economy by 2032.

“As AI rapidly evolves into mainstream use, Cognizant is continually pushing boundaries through strategic partnerships, training programs and platform investments to be an AI-first company,” said Cognizant CEO Ravi Kumar S. “With the launch of Cognizant’s Advanced AI Lab, we’re progressing this effort by investing in state-of-the-art core AI research that establishes our position at the forefront of innovation and our industry. Because we own the client solutioning relationship from end to end, we have a unique line of sight into businesses, industries, and their AI needs. We’re putting dedicated focus on AI research and development to lay the groundwork for better business outcomes and a better future.”

By harnessing the power of Large Language Models (LLMs) as capable knowledge workers, the lab’s researchers and developers will use the Cognizant Neuro™ AI platform to orchestrate LLMs into decision-making AI systems that can positively impact and optimize business outcomes. Moving beyond simple prompt engineering and fine-tuning, these customized AI applications will be designed to support higher value outcomes — from strategic board-level business decisions to enterprise operations including financial, sales, product, and IT support, to day-to-day productivity of individual employees.  

“Cognizant’s Advanced AI Lab is an important partner for us in the research community, and we’ve been fast at work with them already working on simulating brain dynamics in healthy and patient populations,” said Dr. Manish Saggar, Assistant Professor and Director of Brain Dynamics Lab at Stanford University School of Medicine. “I’m excited about the progress we’re making together, as well as its potential impact on not only advancing science but also for developing novel interventions for mental health disorders.”

Specifically, Cognizant’s Advanced AI Lab will focus on the following areas:

  • Researching, designing, evaluating, building, and showcasing innovative AI solutions for business productivity and decision making across various domains
  • Collaborating with external stakeholders, including research institutions, customers, and startups, and engaging in AI-for-good research projects
  • Evangelizing gen AI-enabled decision-making solutions globally, and strengthening Cognizant as a knowledge hub for published, peer-reviewed research on AI
  • Partnering across Cognizant’s business lines and practices to train and upskill associates on new AI solutions as they become available through the Cognizant Neuro™ AI platform
  • Fostering an environment of continuous learning, innovation, and knowledge sharing

The lab will be led by AI entrepreneur and inventor, Babak Hodjat, with AI research activities under the supervision of University of Texas at Austin AI Professor and neuroevolution pioneer, Risto Miikkulainen. In just the last year, their team of researchers and developers have already published 14 papers in academic venues, and they received the Best Pathway to Impact Award at the NeurIPS 2023 Climate Change Workshop for the paper, Discovering Effective Policies for Land-Use Planning.

In addition to the launch of Cognizant’s Advanced AI Lab, Cognizant is supporting enterprise AI adoption through its AI Innovation Studios in London, New York, San Francisco, Dallas, and Bengaluru. These studios serve as inspiration and co-innovation spaces that bring clients and associates together to identify and collaborate on new business solutions.

Cognizant is dedicated to maintaining the highest standards for responsible and ethical AI, focusing on safety, security, privacy, transparency, and inclusion. For additional details on Cognizant’s approach to gen AI and the company’s commitment to responsible AI, visit here. Cognizant also develops research and insights that help leaders make informed decisions to fuel their companies’ success. In partnership with Oxford Economics, Cognizant recently published a study on the economic impact of AI, “New World, New Work,” and intends to release further research on AI’s impact on productivity, tasks, skills, jobs and occupations.

About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

Advertisement
Risto Miikkulainen, Associate Vice President, Evolutionary AI at Cognizant and University of Texas at Austin AI Professor

 

New Cognizant Logo

Photo – https://mma.prnewswire.com/media/2356554/Cognizant_Babak_Hodjat.jpg
Photo – https://mma.prnewswire.com/media/2356555/Cognizant_Risto_Miikkulainen.jpg
Logo – https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cognizant-unveils-advanced-artificial-intelligence-lab-to-accelerate-ai-research-and-innovation-302082185.html

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

SciBase announces outcome of directed issue and preliminary outcome of rights issue

Published

on

scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue

STOCKHOLM, Jan. 13, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase” or the “Company”) today announces the preliminary outcome of the capital raise, consisting of a rights issue of units of approximately SEK 59.3 million (the “Rights Issue”) and a directed issue of units, deviating from existing shareholders’ preferential rights, of approximately SEK 22.5 million (the “Directed Issue”), that was announced on  November 12, 2024 (the “Capital Raise”). All 16,669,624 units in the Directed Issue have been subscribed and paid for, and thus the Board of Directors of SciBase plans to resolve on allocation of units to the investors in the Directed Issue on January 14, 2025. The preliminary outcome of the Rights Issue indicates that 22,916,119 units, corresponding to approximately 52.2 percent of the Rights Issue, were subscribed for both with and without the support of unit rights. The Rights Issue was covered to approximately 50.4 percent by subscription commitments, guarantee commitments and declarations of intentions to subscribe for units. Consequently, the guarantee commitments will not be utilized. Through the Rights Issue, the Company will initially receive approximately SEK 30.9 million, and through the Directed Issue the Company will initially receive approximately SEK 22.5 million, before issuance costs. Should all attached warrants of series TO 3 (the “Warrants”), relating to the issued units in the Capital Raise, be exercised, the Company may receive an additional amount of minimum SEK 53.4 million and maximum SEK 89.1 million.

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION REQUIRES ADDITIONAL PROSPECTUSES, REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH LAW, IS PROHIBITED, OR OTHERWISE CONTRARY TO APPLICABLE RULES IN SUCH JURISDICTION OR CANNOT BE DONE WITHOUT APPLICATION OF EXEMPTIONS FROM SUCH MEASURES. SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.

Allocation of units in the Directed Issue

All units in the Directed Issue have been subscribed and paid for, and thus, the Board of Directors of SciBase intends to resolve on the allocation of 16,669,624 units in the Directed Issue, on January 14, 2025, in conjunction with the Company’s resolution on allocation based on the final outcome in the Rights Issue. Each unit in the Directed Issue consists of three (3) shares and three (3) Warrants. Through the Directed Issue, the Company will initially receive approximately SEK 22.5 million before issuance costs.

Outcome in the Rights Issue

The subscription period in the Rights Issue ended on  January 13, 2025 and the preliminary subscription summary indicates that 22,674,031 units, corresponding to approximately SEK 30.6 million, or approximately 51.6 percent of the Rights Issue, were subscribed for with the support of units rights and 242,088 units, corresponding to approximately SEK 0.3 million, or approximately 0.6 percent of the Rights Issue, were subscribed for without the support of unit rights, for a combined total subscription, with and without the support of unit rights, of approximately 52.2 percent. The Rights Issue was covered to approximately 50.4 percent by subscription commitments, guarantee commitments and declarations of intentions to subscribe for units. Consequently, the guarantee commitments will not be utilized. Through the Rights Issue, the Company will initially receive approximately SEK 30.9 million before issuance costs.

Allocation of units in the Rights Issue will be conducted according to the principles specified in the EU growth prospectus issued in connection with the Rights Issue, published on December 20, 2024 (the “Prospectus“). Notifications regarding the allocation of units subscribed without the support of unit rights will be sent via contract notes to those allocated units. Nominee-registered shareholders will receive allocation notifications in accordance with the procedures of each respective nominee.

Number of shares and share capital

As a result of the Rights Issue, the Company’s share capital increases by SEK 3,437,417.85, from SEK 10,976,920.20 to SEK 14,414,338.05, through the issuance of 68,748,357 shares. Thus, the number of shares increases from 219,538,404 to 288,286,761 shares. The dilution effect amounts to 23.8 percent.

Through the Directed Issue, the number of shares in SciBase will increase by 50,008,872 shares, from a total of 288,286,761 shares (calculated on the total number of shares in the Company after the Rights Issue) to a total of 338,295,633 shares. As a result of the Directed Issue, the Company’s share capital will increase by SEK 2,500,443.60, from SEK 14,414,338.05 (calculated on the Company’s share capital after the Rights Issue) to SEK 16,914,781.65. The dilution effect from the Directed Issue amounts to approximately 14.8 percent of the number of shares in the Company (calculated on the total number of shares in the Company after the Rights Issue and the Directed Issue).

Advertisement

Should all Warrants, issued in the Capital Raise, be exercised, the number of shares will increase by an additional 118,757,229 and the share capital will increase by an additional SEK 5,937,861.45, corresponding to an additional dilution effect of approximately 26.0 percent of the total number of shares and votes in the Company (calculated on the total number of shares in the Company after the Rights Issue, the Directed Issue and full exercise of all Warrants).

Trading in BTU

Trading in paid subscribed units (“BTU“) will continue on Nasdaq First North Growth Market up to, and including, January 17, 2025.

Warrants

One (1) Warrant entitles to subscription of one (1) new share in the Company during the period from and including November 24, 2025, until and including, December 5, 2025. The subscription price when exercising the Warrants will be determined as 80 percent of the volume-weighted average price of the Company’s shares on Nasdaq First North Growth Market during the measurement period from and including November 10, 2025, until and including, November 21, 2025, however, no less than SEK 0.45 and no more than SEK 0.75 per share.

Advisors

SciBase has engaged Penser by Carnegie as financial advisor and Advokatfirman Schjødt as legal advisor in connection with the Capital Raising.

Certified Advisor (CA):

Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: [email protected]

For additional information, please contact:
Pia Renaudin, CEO, tel. +46732069802, e-mail: [email protected] 

Advertisement

The information was submitted for publication, through the agency of the contact person set out above, at 8.00 PM on January 13, 2025.

About SciBase

SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to enhance diagnostic accuracy, ensuring proactive skin health management.

Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.

Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.

The Company has been listed on Nasdaq First North Growth Market since June 2, 2015, and the Certified Advisor is Carnegie Investment Bank AB (publ). For more information, visit www.SciBase.com. All press releases and financial reports can be found here: http://investors.scibase.se/sv/pressmeddelanden.

Important information

Publication, release or distribution of this press release may in certain jurisdictions be subject to legal restrictions and persons in the jurisdictions where this press release has been made public or distributed should be informed of and follow such legal restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer or solicitation to buy or subscribe for any securities in SciBase in any jurisdiction, either from SciBase or from anyone else.

This press release is not a prospectus according to the definition in Regulation (EU) 2017/1129 (the “Prospectus Regulation“) and has not been approved by any regulatory authority in any jurisdiction. Acquisition of Units in the Rights Issue should only be made on the basis of the information in the formal Prospectus published by the Company in connection with the Rights Issue and which is made available on the Company’s website, https://investors.scibase.se/en/mid-disclaimer/107/83.

This press release does not constitute an offer or solicitation to buy or subscribe for securities in the United States. The securities mentioned herein may not be sold in the United States without registration, or without an exemption from registration, under the U.S. Securities Act from 1933 (“Securities Act“) and may not be offered or sold within the United States without being registered, covered by an exemption from, or part of a transaction that is not subject to the registration requirements according to the Securities Act. There is no intention to register any securities mentioned herein in the United States or to issue a public offering of such securities in the United States. The information in this press release may not be released, published, copied, reproduced or distributed, directly or indirectly, wholly or in part, in or to Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Switzerland, Singapore, South Africa, the United States or any other jurisdiction where the release, publication or distribution of this information would violate current rules or where such an action is subject to legal restrictions or would require additional registration or other measures beyond those that follow from Swedish law. Actions in contravention of this instruction may constitute a violation of applicable securities legislation.

Advertisement

Forward-looking statements

This press release contains forward-looking statements related to the Company’s intentions, estimates or expectations with regard to the Company’s future results, financial position, liquidity, development, outlook, estimated growth, strategies and opportunities as well as the markets in which the Company is active. Forward-looking statements are statements that do not refer to historical facts and can be identified by the use of terms such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “will,” “may,” “implies,” “should,” “could” and, in each case, their negative, or comparable terminology. The forward-looking statements in this press release are based on various assumptions, which in several cases are based on further assumptions. Although the Company believes that the assumptions reflected in these forward-looking statements are reasonable, there is no guarantee that they will occur or that they are correct. Since these assumptions are based on assumptions or estimates and involve risks and uncertainties, actual results or outcomes, for many different reasons, may differ materially from those what is stated in the forward-looking statements. Due to such risks, uncertainties, eventualities and other significant factors, actual events may differ materially from the expectations that expressly or implicitly are contained in this press release through the forward-looking statements. The Company does not guarantee that the assumptions which serve as a basis for the forward-looking statements in this press release are correct, and each reader of the press release should not rely on the forward-looking statements in this press release. The information, opinions and forward-looking statements that expressly or implicitly are stated herein are provided only as of the date of this press release and may change. Neither the Company nor any other party will review, update, confirm or publicly announce any revision of any forward-looking statement to reflect events that occur or circumstances that arise with respect to the contents of this press release, beyond what is required by law or Nasdaq First North Growth Market Rulebook for Issuers of Shares.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue,c4090867

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/scibase-announces-outcome-of-directed-issue-and-preliminary-outcome-of-rights-issue-302349666.html

Continue Reading

Fintech PR

Strategic Value Partners invests €200 million in Bjelin Group

Published

on

strategic-value-partners-invests-e200-million-in-bjelin-group

HELSINGBORG, Sweden, Jan. 13, 2025 /PRNewswire/ — Strategic Value Partners, LLC (together with its affiliates, “SVP”), a global alternative investment firm with approximately $19 billion of assets under management, and Bjelin Group today announced the signing of an agreement whereby funds managed by SVP will make a €200 million preferred equity investment in Bjelin Group to facilitate its long-term growth ambitions.

Bjelin Group AB is fully owned by the Pervan family and its assets comprise a 51% ownership stake in Välinge Group and a 100% ownership stake in Bjelin Industries. 49% of the shares of Välinge Group are owned by KIRKBI Invest A/S and Välinge Group management.

Välinge Group has two business segments. A licensing business for flooring and furniture applications (Välinge Innovation AB) and an industrial business with large scale production of flooring with Woodura® surface technology and furniture in Sweden and Croatia. Bjelin Industries is a veneer, flooring and furniture manufacturing business with production facilities in Croatia.

Bjelin Group AB will acquire all shares in Välinge’s industrial business, which will be merged with Bjelin Industries. The acquisition is expected to be completed during the first quarter of 2025, pending customary closing conditions and governmental approval. Funds managed by SVP will make a €200 million preferred equity investment in Bjelin Group to finance this acquisition and provide capital for additional major investments in Woodura® and veneer production with the aim to create a world leading sustainable wood flooring company. The Pervan family will maintain an ownership stake of 97% in Bjelin Group AB.

Välinge Innovation AB, which is a leading R&D, IP and licensing company, mainly related to flooring and furniture technology, anticipates that it will seek a public listing at the appropriate time as the potential high growth of Woodura® flooring is expected to benefit Välinge’s license revenues.

“Our partnership with SVP is more than a financial investment. Bjelin Industries has a key relationship with SVP’s portfolio company, Pfleiderer, a leading manufacturer of high-quality wood-based products including HDF which is used as a core in our Woodura® flooring, laminates for kitchen, furniture, and construction applications. We are excited about the potential to expand the collaboration between Pfleiderer and Bjelin with a wide range of potential commercial and technical cooperation opportunities. Fredrik Alfredsson, who has a long international experience within the flooring business, will be appointed CEO of Bjelin Group,” said Darko Pervan, Chairman and founder of Bjelin Group.

Brian Himot, Head of Structured Capital at SVP, said: “Over the past 30 years, Darko Pervan has built a leading IP licensing business and set the foundations to create a market leading industrial manufacturing business. We are delighted to be partnering with an entrepreneur of his standing at a key moment for the development of the manufacturing business. SVP has developed expertise in these types of partnership-oriented investments with founders and family offices. We look forward to working closely with the Pervan family to drive value for the business.”

“During the past 7 years we have been involved in large scale Woodura® production, and a major part of our license revenues have been invested to develop and commercialize this sustainable and competitive flooring technology. Välinge and Bjelin have invested about €500 million to build large-scale production and marketing capabilities and to secure the oak material which is used as a surface in floors with Woodura® technology. This has provided a lot of new knowledge and patents. Our work to scale up the technology is now complete, and we are convinced that our industrial group combined with Bjelin Industries will be very successful.  We believe that this will increase our license revenues and will give a very good long-term return on our investment,” said Niclas Håkansson, CEO of Välinge Innovation AB.

Citi and Nordea acted as joint placement agents. SVP was advised by Kirkland and Ellis, Schjødt and Wolf Theiss as legal counsel. Bjelin Group was advised by Mannheimer Swartling as legal counsel.

The Woodura® word mark and logo are registered trademarks owned by Välinge Innovation AB and any use of such marks is under license.

Advertisement

About SVP

SVP is a global alternative investment firm that focuses on special situations, private equity, opportunistic credit and financing opportunities. The firm uses a combination of sourcing, financial and operational expertise to unlock value in its portfolio companies. Today SVP manages approximately $19 billion in assets under management, and since inception, has invested more than $50 billion of capital, including more than $18 billion in Europe. The firm, established by Victor Khosla in 2001, has over 200 employees, including more than 100 investment professionals, across its main offices in Greenwich (CT) and London, and a presence in Tokyo. Learn more at www.svpglobal.com

Contact:
Greenbrook
James Madsen / Ksenia Galouchko
[email protected]

View original content:https://www.prnewswire.co.uk/news-releases/strategic-value-partners-invests-200-million-in-bjelin-group-302349646.html

Continue Reading

Fintech PR

HashKey Receives In-Principle Approval for Dubai VASP License

Published

on

hashkey-receives-in-principle-approval-for-dubai-vasp-license

HONG KONG, Jan. 13, 2025 /PRNewswire/ — HashKey Group (“HashKey”), a leading end-to-end digital asset financial services group in Asia, today announced that HashKey MENA FZE, a member of the HashKey Group, has received an In-Principle Approval (IPA) from the Dubai Virtual Assets Regulatory Authority (VARA) for its Virtual Asset Service Provider (VASP) license application. This regulatory approval reinforces HashKey Group’s position as a trusted leader in the virtual asset industry, enabling HashKey to deliver secure and transparent services globally.

Upon final approval, the VASP license will authorise HashKey MENA FZE to offer Virtual Asset Exchange Services and Virtual Asset Broker-Dealer Services in and from the Emirate of Dubai to retail investors, qualified investors, and institutional investors. This milestone also marks significant progress for HashKey OTC, the Group’s over-the-counter trading arm, as it expands its regulated offerings in the Middle East. In doing so, HashKey OTC underscores its commitment to a compliance-first approach, offering investors a secure and efficient environment for digital asset trading.

Ben El-Baz, Managing Director of HashKey Global said “We view this milestone as a pivotal moment for us, as it positions us in the future to serve both retail and institutional clients in the UAE with enhanced accessibility and local currency support. This achievement empowers us to deliver trusted, compliant, and seamless virtual asset services, enabling clients to deposit and withdraw in their local currency. At HashKey Global, we are deeply committed to fostering growth in Dubai and the broader MENA region by combining regulatory excellence and a customer-first approach. This marks the beginning of an exciting journey to drive sustainable growth and build lasting relationships in this dynamic market.”

HashKey Group holds licenses in Hong Kong, Singapore, Japan, and Bermuda, has a VASP registration in Ireland, and is actively pursuing a MiCA license in Europe to further strengthen its global regulatory footprint.

About HashKey Group

HashKey Group is a leading digital asset financial services group in Asia with global operations in regions such as Hong Kong, Singapore, Japan, Ireland and Bermuda. Since 2018, HashKey Group has built a global Web3 ecosystem within a high-compliance regulatory framework, including HashKey Exchange, a licensed virtual asset exchange regulated by the Hong Kong SFC; HashKey Global, the global flagship digital asset exchange; HashKey Capital, a global asset manager investing exclusively in blockchain technology and digital assets; HashKey OTC, the compliant over-the-counter (OTC) trading arm of HashKey Group, HashKey Cloud, a leading provider of global Web3 infrastructure; and HashKey Tokenisation, a tokenisation services provider.

HashKey Group also possesses a rich on-chain ecosystem, having developed the Ethereum Layer 2, HashKey Chain, and has listed the HashKey platform token HSK. HashKey Group is committed to driving the mass application of blockchain technology, aiming to provide trustworthy and accessible digital asset services to one billion global users.

Disclaimer

Please be aware that certain services, features, and campaigns may not be available in your jurisdiction. In particular, digital asset exchanges operated under HashKey Group does not service clients from Hong Kong (for HashKey Global), Mainland China and the United States and certain other jurisdictions in compliance with laws and regulations. HashKey is subject to the regulatory approval and receipt of the Financial Services Permission

About HashKey OTC

Advertisement

HashKey OTC is a leading provider of bespoke digital asset trade execution services, offering a secure and regulated trading environment for institutional and professional clients. With a strong emphasis on compliance and security, HashKey OTC delivers spot trades, crypto on/off ramp services, and access to a diverse range of digital assets and fiat currencies.

For media inquiries, please visit: Website | X | Telegram 

Disclaimer: The information shared in this article is for general informational purposes only. Nothing shared in this article constitutes an offer, recommendation, or solicitation to buy, sell, or engage in any specific asset or investment strategy.

About HashKey Global

HashKey Global is the flagship digital asset exchange under HashKey Group, offering licensed digital asset trading services to users worldwide, and becomes one of the fastest-growing crypto exchanges in 2024. HashKey Global has obtained a license from the Bermuda Monetary Authority providing mainstream trading and service products such as LaunchPad, contracts, leverage, etc.

Please read our latest Disclaimer.
For more details, please visit global.hashkey.com   
Follow HashKey on  X, Telegram, and Discord

View original content:https://www.prnewswire.co.uk/news-releases/hashkey-receives-in-principle-approval-for-dubai-vasp-license-302349440.html

Continue Reading

Trending